To check effect of Virechan Karma with Danti Haritaki Avaleha in Anaemia

A Clinical study of Virechan Karma with Danti Haritaki Avaleha in Pandu (Anaemia) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055448

Enrollment

Registered

2023-07-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D539- Nutritional anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed as Pandu with Hb concentration between 8gm/dL-11gm/dL and indicated for Virechan

Exclusion criteria

Exclusion criteria: Patients Contra-Indicated for Virechan Karma o Acute haemorrhagic anaemia i.e. post-operative, post trauma o Pregnant women and Post Partum females will be excluded o Patients having haemorrhoids, peptic ulcer,malignancy, Thalassaemias,sickle cell anaemia

Design outcomes

Primary

Measure	Time frame
Increase Hb ConcentrationTimepoint: 30th & 45th day from Snehapana	—

Secondary

Measure	Time frame
Reduction in classical Signs & Symptoms of Pandu like Pandu Varna of Twacha, Nakha, Netra (Pallor of skin; nails; eyes),Daurbalya (Generalised weakness),Aayasena shwas(Dyspnoea on exertion),Bhrama (Giddiness),Shirahshool (Headache),Gatrashool(Bodyache),Sadana(Fatigue),Tandra(Sleepiness) Timepoint: 30th & 45th day from Abhyantar Snehapana (Internal oleation)	—

Countries

India

Contacts

Public ContactDr Anjali Deshmukh

Bharati Vidyapeeth, Deemed to be University, Pune

manju.matekar@bharatividyapeeth.edu9890254424

Outcome results